Haemonetics Corporation (HAE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Haemonetics Corporation (HAE) has a cash flow conversion efficiency ratio of 0.089x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($70.94 Million) by net assets ($796.32 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Haemonetics Corporation - Cash Flow Conversion Efficiency Trend (1992–2026)
This chart illustrates how Haemonetics Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Haemonetics Corporation debt and liabilities for a breakdown of total debt and financial obligations.
Haemonetics Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Haemonetics Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hub Group Inc
NASDAQ:HUBG
|
0.016x |
|
China Railway Hi-tech Industry Corp Ltd
SHG:600528
|
0.101x |
|
KANSAI PAINT SPON.ADR/1/2
F:KAP0
|
N/A |
|
Jiangsu Lihua Animal Husbandry Co Ltd
SHE:300761
|
0.087x |
|
Elekta AB (publ)
ST:EKTA-B
|
0.067x |
|
Bangkok Expressway and Metro Public Company Limited
BK:BEM
|
-0.137x |
|
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131
|
0.033x |
|
Levi Strauss & Co Class A
NYSE:LEVI
|
0.124x |
Annual Cash Flow Conversion Efficiency for Haemonetics Corporation (1992–2026)
The table below shows the annual cash flow conversion efficiency of Haemonetics Corporation from 1992 to 2026. For the full company profile with market capitalisation and key ratios, see Haemonetics Corporation market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | $893.76 Million | $293.22 Million | 0.328x | +48.19% |
| 2025-03-31 | $820.84 Million | $181.72 Million | 0.221x | +16.93% |
| 2024-03-31 | $959.96 Million | $181.75 Million | 0.189x | -43.28% |
| 2023-03-31 | $818.00 Million | $273.06 Million | 0.334x | +45.22% |
| 2022-03-31 | $749.42 Million | $172.26 Million | 0.230x | +54.57% |
| 2021-03-31 | $731.67 Million | $108.81 Million | 0.149x | -44.82% |
| 2020-03-31 | $587.11 Million | $158.22 Million | 0.269x | +13.00% |
| 2019-03-31 | $667.87 Million | $159.28 Million | 0.238x | -18.56% |
| 2018-03-31 | $752.43 Million | $220.35 Million | 0.293x | +35.59% |
| 2017-03-31 | $739.61 Million | $159.74 Million | 0.216x | +27.60% |
| 2016-03-31 | $719.98 Million | $121.86 Million | 0.169x | +9.95% |
| 2015-03-31 | $826.12 Million | $127.18 Million | 0.154x | -7.36% |
| 2014-03-31 | $839.61 Million | $139.52 Million | 0.166x | +50.25% |
| 2013-03-31 | $769.18 Million | $85.07 Million | 0.111x | -29.50% |
| 2012-03-31 | $735.08 Million | $115.32 Million | 0.157x | -12.81% |
| 2011-03-31 | $686.14 Million | $123.45 Million | 0.180x | -18.33% |
| 2010-03-31 | $593.12 Million | $130.67 Million | 0.220x | +2.21% |
| 2009-03-31 | $539.88 Million | $116.36 Million | 0.216x | +37.14% |
| 2008-03-31 | $494.19 Million | $77.67 Million | 0.157x | -9.79% |
| 2007-03-31 | $479.65 Million | $83.56 Million | 0.174x | -10.13% |
| 2006-03-31 | $441.65 Million | $85.62 Million | 0.194x | -3.32% |
| 2005-03-31 | $355.13 Million | $71.21 Million | 0.201x | -24.82% |
| 2004-03-31 | $279.75 Million | $74.61 Million | 0.267x | +36.35% |
| 2003-03-31 | $223.24 Million | $43.67 Million | 0.196x | +43.70% |
| 2002-03-31 | $236.82 Million | $32.24 Million | 0.136x | -51.91% |
| 2001-03-31 | $215.52 Million | $61.01 Million | 0.283x | +9.31% |
| 2000-03-31 | $206.44 Million | $53.47 Million | 0.259x | +70.53% |
| 1999-03-31 | $221.90 Million | $33.70 Million | 0.152x | +44.95% |
| 1998-03-31 | $194.70 Million | $20.40 Million | 0.105x | -11.59% |
| 1997-03-31 | $225.30 Million | $26.70 Million | 0.119x | -53.07% |
| 1996-03-31 | $217.00 Million | $54.80 Million | 0.253x | +212.75% |
| 1995-03-31 | $193.20 Million | $15.60 Million | 0.081x | -51.91% |
| 1994-03-31 | $160.80 Million | $27.00 Million | 0.168x | -40.74% |
| 1993-03-31 | $126.70 Million | $35.90 Million | 0.283x | +36.55% |
| 1992-03-31 | $90.60 Million | $18.80 Million | 0.208x | -- |
About Haemonetics Corporation
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information tech… Read more